Provide quality insulin to children with Type 1 diabetes: Keralam child panel

Provide quality insulin to children with Type 1 diabetes: Keralam child panel Updated – August 19, 2026 09: 25 pm IST – Thiruvananthapuram.

Key points

• The Mittayi scheme was introduced to provide comprehensive backing and continuous treatment for children and adolescents with Type 1 diabetes through Mittayi clinics.
• Manoj Kumar, commission chairperson whose term has since concluded, and members Shajesh Bhaskar and Wilson F.
• The petitioners had argued that for the past year-and-a-half, low-quality insulin was being distributed through the Mittayi scheme.
• The parents of children with Type 1 diabetes remarked they had submitted a number of complaints but the difficulty was not addressed.
• They had alleged that the previous LDF administration had cited financial diffculties for making the shift to regular insulin instead of rapid-acting insulin.

In practice, the Kerala State Commission for Protection of Child Rights has directed the Health and the Social Justice department authorities to provide quality insulin to children with Type 1 diabetes.

In practice, the commission directed the Health director, Social Justice Secretary, and the Kerala Social Security Mission (KSSM) executive director to take steps to create quality medicines and benefits available as per the 2018 KSSM scheme.

For context, the commission directed the KSSM executive director to roll back the changes brought in the Mittayi scheme in the 2025-26 financial year and take steps to provide to children with medicines and other benefits that were being provided from the time the Mittayi clinics began functioning.

For context, the Mittayi scheme was introduced to provide comprehensive backing and continuous treatment for children and adolescents with Type 1 diabetes through Mittayi clinics.

Meanwhile, a bench of K.V. Manoj Kumar, commission chairperson whose term has since concluded, and members Shajesh Bhaskar and Wilson F. Was acting on a petition from Bushra Shihab and others of the Type 1 Diabetes Foundation (Kerala) and Abdul Jaleel P.T. Of the Type 1 Diabetic Welfare Society. The commission has sought an action-taken report within 45 days.

Meanwhile, the petitioners had argued that for the past year-and-a-half, low-quality insulin was being distributed through the Mittayi scheme. This was affecting children's health and disrupting their education since they developed diabetic ketoacidosis (DKA).

They had alleged that the previous LDF administration had cited financial diffculties for making the shift to regular insulin instead of rapid-acting insulin. The authorities had informed them that even regular insulin would not be available for an entire month for children.

In practice, the parents of children with Type 1 diabetes remarked they had submitted a number of complaints but the difficulty was not addressed.

In short, provide quality insulin to children with Type 1 diabetes: Keralam child panel is the central thread here, and readers can expect follow-up reporting as the picture becomes clearer.